Showing results (241-250 of 1,342) with videos related to
Sort By:
Pageof 135
Diabetes & Metabolism|November 18, 2017
Renal outcomes with dipeptidyl peptidase-4 inhibitorsA J Scheen, P DelanayeDiabetes & Metabolism|February 4, 2017
Effects of reducing blood pressure on renal outcomes in patients with type 2 diabetes: Focus on SGLT2 inhibitors and EMPA-REG OUTCOMEA J Scheen, P DelanayeRevue Medicale De Liege|January 9, 2014
[Rationale supporting basal insulin-incretin combined therapies in type 2 diabetes]A J Scheen, N PaquotRevue Medicale De Liege|August 16, 2012
[Type 2 diabetes: journey in the heart of a complex disease]A J Scheen, N PaquotRevue Medicale De Liege|December 7, 2010
[Medication of the month. Dabigatran etixilate (Pradaxa): an oral anticoagulant acting as a direct selective inhibitor of thrombin]P Lancellotti, A J ScheenRevue Medicale De Liege|September 12, 2017
[Which antidiabetic agent in a patient with type 2 diabetes and heart failure ?]A J Scheen, N PaquotRevue Medicale De Liege|May 14, 2004
[Clinical study of the month. REVERAL and PROVE-IT: confirmation of the concept " the lower, the better" for cholesterol therapy in patients with coronary heart disease]A J Scheen, H KulbertusRevue Medicale De Liege|January 25, 2013
[Management of hyperglycaemia in type 2 diabetes: a patient-centered approach]A J Scheen, C MathieuDiabetes & Metabolism|March 27, 2013
Metformin revisited: a critical review of the benefit-risk balance in at-risk patients with type 2 diabetesA J Scheen, N PaquotRevue Medicale De Liege|November 5, 1999
[Type II diabetes: diagnostic approaches, glycemia objectives and therapeutic strategies]A J Scheen, N PaquotPageof 135